Publicacións en colaboración con investigadores/as de Hospital Universitario Pío del Río Hortega (15)

2024

  1. Human T-lymphotropic virus-1 infection among Latin American pregnant women living in Spain

    IJID Regions, Vol. 10, pp. 146-149

2023

  1. Adult T-cell leukemia/lymphoma in HTLV-1 non-endemic regions

    Journal of Clinical Virology, Vol. 167

  2. HTLV-1-associated myelopathy in Spain

    Journal of Clinical Virology, Vol. 169

2021

  1. Considerations on HTLV-1 infection in Spain

    Medicina Clinica

  2. Short Communication: Impact of COVID-19 on Case Reporting for HTLV and HIV-2 in Spain

    AIDS Research and Human Retroviruses, Vol. 37, Núm. 8, pp. 610-612

2020

  1. COVID-19 comes 40 years after aids – Any lesson?

    AIDS Reviews, Vol. 22, Núm. 1, pp. 1-15

  2. Covid-19 comes 40 years after aids – any lesson?

    AIDS Reviews, Vol. 22, Núm. 2, pp. 63-77

  3. Hospital admissions in individuals with HTLV-1 infection in Spain

    AIDS, Vol. 34, Núm. 7, pp. 1019-1027

2019

  1. Clinical presentation of individuals with human T-cell leukemia virus type-1 infection in Spain

    Open Forum Infectious Diseases, Vol. 6, Núm. 2

2017

  1. Drug resistance mutations in HIV-2 patients failing raltegravir and influence on dolutegravir response

    Journal of Antimicrobial Chemotherapy, Vol. 72, Núm. 7, pp. 2083-2088

  2. HIV type 2 epidemic in Spain: Challenges and missing opportunities

    AIDS, Vol. 31, Núm. 10, pp. 1353-1364

  3. Human T-lymphotropic virus type 1 infection and disease in Spain

    AIDS, Vol. 31, Núm. 12, pp. 1653-1663

2014

  1. HIV-2 viral tropism influences CD4+ T cell count regardless of viral load

    Journal of Antimicrobial Chemotherapy, Vol. 69, Núm. 8, pp. 2191-2194

  2. X4 tropic viruses are on the rise in recent HIV-1 seroconverters in Spain

    AIDS, Vol. 28, Núm. 11, pp. 1603-1609

2008

  1. Low rate of adverse hepatic events associated with fosamprenavir/ritonavir-based antiretroviral regimens

    HIV Clinical Trials, Vol. 9, Núm. 5, pp. 309-313